Damages for Pharmaceutical patents infringement: The case of Raloxifene
![](https://www.zbm-patents.eu/2019/wp-content/uploads/2023/11/nov2023m.jpg)
(NEW ARTICLE) Raloxifene, a drug used to treat osteoporosis, has been at the center of a legal dispute in Spain between the pharmaceutical company ELI LILLY, the patent holder, and the… | By Yahel Contreras
Read article.